ADAM LILLO: Open Payments
NPI 1265187462 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 40 payments from 11 companies in 2025. Trend: 2023 $1,882 · 2024 $1,362 · 2025 $791
Food & beverage: $787Education: $3
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $208 |
| Novartis Pharmaceuticals Corporation | 7 | $128 |
| Merck Sharp & Dohme LLC | 6 | $101 |
| Amgen Inc. | 5 | $83 |
| Regeneron Healthcare Solutions, Inc. | 2 | $73 |
| Esperion Therapeutics, Inc. | 3 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Boston Scientific Corporation | 1 | $23 |
Products named: VYNDAQEL, LEQVIO, VERQUVO, REPATHA, EVKEEZA, ELIQUIS, NEXLETOL, LifeVest.
Industry payments across FL — which companies pay providers there.
